Matthew Frank, MD, PhD
Dr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. He predominantly cares for patients with high-risk lymphoma and other blood cancers and is a lead investigator of clinical trials evaluating immunotherapies, including chimeric antigen receptor (CAR) T-cell therapy. His group’s research goals includes developing methods to identify those at high risk of develop CAR T-cell related toxicity or high-risk of relapsing after CAR T-cell therapies and then develop strategies to improve the clinical outcomes for those who undergo these therapies.
NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.